Developed by:
The European Restless Legs Syndrome Study Group (EURLSSG)

Objective:
To measure the severity of a treatment complication in restless legs syndrome patients

Copyright:
ASRS © EURLSSG www.eurlssg.org, 2008. All Rights Reserved.

Reference publications:
Garcia-Borreguero D, Kohnen R, Hogl B, Ferini-Strambi L, Hadjigeorgiou GM, Hornyak M, et al. Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndrome. Sleep Med. 2007 Aug;8(5):455-63.

Hogl B, Garcia-Borreguero D, Kohnen R, Ferini-Strambi L, Hadjigeorgiou G, Hornyak M, et al. Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study. J Neurol. 2010 Sep 11;257(2):230-7.


Conditions of use:

1. User Agreement:

User is required to complete and sign a User Agreement in which specific conditions requested by the Authors are detailed.


2. Access fees:

Authors' royalty fees:

- In academic research and individual clinical practice: free of charge

- In commercial studies (1) involving "for-profit" organizations and academic studies funded by commercial companies:
• Less than 50 patients included in the study = 3500 €* per study
• From 50 to 199 patients included in the study = 7000 €* per study
• From 200 to 499 patients included in the study = 15000 €* per study
• From 500 to 999 patients included in the study = 20000 €* per study
• More than 1.000 patients included in the study = 25000 €* per study

These fees are payable to MAPI Research Trust on behalf of the EURLSSG.

Other specific conditions requested by the Authors are detailed in the User Agreement.

Distribution fees are requested according to the study design and context of use of the questionnaire:

- In not-funded academic research (1) and individual clinical practice: free of charge

- In funded academic research (2): 300 €* per study + 50 €* per language version

- In commercial studies (3) involving "for-profit" organizations: 600 €* per study + 250 €* per language version.

* excluding VAT

(1) Not funded academic research: if the project is not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds then fees are waived.

(2) Funded academic research: projects receiving funding from commerce, government, EU should anticipate paying the corresponding fees.

(3) Commercial studies (industry, CRO, any for-profit companies)


Review copy:

Original UK English version available for review purpose only. Please click here to access.


New translations:

For the production of new translations to be used in commercial studies, each translation shall be coordinated by Mapi Institute.


Contact information:

MAPI Research Trust

27 rue de la Villette
F - 69003 LYON
Tel: +33 4 72 13 65 75
Fax: +33 4 72 13 55 73
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Please have the User Agreement completed, dated and signed and return one original copy to MAPI Research Trust by post. As soon as we receive it, we will process your request.


More information on the ASRS on PROQOLID


[ BACK ]